Rank | Gene Set | Z-score |
---|---|---|
1 | epoxygenase P450 pathway (GO:0019373) | 7.35565158 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.81937436 |
3 | L-phenylalanine catabolic process (GO:0006559) | 6.81937436 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.56031982 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.56031982 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.20833978 |
7 | glyoxylate metabolic process (GO:0046487) | 5.81629140 |
8 | omega-hydroxylase P450 pathway (GO:0097267) | 5.76146098 |
9 | tryptophan catabolic process (GO:0006569) | 5.65584439 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.65584439 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.65584439 |
12 | cysteine metabolic process (GO:0006534) | 5.56656007 |
13 | lysine catabolic process (GO:0006554) | 5.55385979 |
14 | lysine metabolic process (GO:0006553) | 5.55385979 |
15 | kynurenine metabolic process (GO:0070189) | 5.51907892 |
16 | tryptophan metabolic process (GO:0006568) | 5.29805411 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.27259474 |
18 | bile acid biosynthetic process (GO:0006699) | 5.27143722 |
19 | sulfur amino acid catabolic process (GO:0000098) | 5.25494746 |
20 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.23317706 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.18520860 |
22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.17841117 |
23 | fibrinolysis (GO:0042730) | 4.96105558 |
24 | amino-acid betaine metabolic process (GO:0006577) | 4.85344161 |
25 | homocysteine metabolic process (GO:0050667) | 4.76145497 |
26 | ethanol oxidation (GO:0006069) | 4.73473562 |
27 | intestinal absorption (GO:0050892) | 4.71562814 |
28 | blood coagulation, intrinsic pathway (GO:0007597) | 4.71395601 |
29 | cellular ketone body metabolic process (GO:0046950) | 4.69630420 |
30 | urea metabolic process (GO:0019627) | 4.67128116 |
31 | urea cycle (GO:0000050) | 4.67128116 |
32 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.66704080 |
33 | serine family amino acid catabolic process (GO:0009071) | 4.65964769 |
34 | drug transmembrane transport (GO:0006855) | 4.54133501 |
35 | phenylpropanoid metabolic process (GO:0009698) | 4.52788902 |
36 | cellular glucuronidation (GO:0052695) | 4.52771048 |
37 | bile acid metabolic process (GO:0008206) | 4.51406144 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 4.46999149 |
39 | oxidative demethylation (GO:0070989) | 4.43728943 |
40 | high-density lipoprotein particle remodeling (GO:0034375) | 4.42191093 |
41 | short-chain fatty acid metabolic process (GO:0046459) | 4.40331645 |
42 | drug catabolic process (GO:0042737) | 4.40121515 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 4.36400457 |
44 | nitrogen cycle metabolic process (GO:0071941) | 4.36347868 |
45 | alpha-amino acid catabolic process (GO:1901606) | 4.36110572 |
46 | plasma lipoprotein particle assembly (GO:0034377) | 4.30957022 |
47 | negative regulation of fibrinolysis (GO:0051918) | 4.29579556 |
48 | complement activation, alternative pathway (GO:0006957) | 4.28052932 |
49 | negative regulation of hemostasis (GO:1900047) | 4.25401772 |
50 | negative regulation of blood coagulation (GO:0030195) | 4.25401772 |
51 | intestinal cholesterol absorption (GO:0030299) | 4.24285940 |
52 | aspartate family amino acid catabolic process (GO:0009068) | 4.23244172 |
53 | benzene-containing compound metabolic process (GO:0042537) | 4.21684758 |
54 | acetyl-CoA metabolic process (GO:0006084) | 4.19770458 |
55 | hormone catabolic process (GO:0042447) | 4.19303534 |
56 | glucuronate metabolic process (GO:0019585) | 4.19204284 |
57 | uronic acid metabolic process (GO:0006063) | 4.19204284 |
58 | protein carboxylation (GO:0018214) | 4.16860539 |
59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16860539 |
60 | regulation of protein activation cascade (GO:2000257) | 4.16620547 |
61 | fatty acid beta-oxidation (GO:0006635) | 4.16235055 |
62 | cellular amino acid catabolic process (GO:0009063) | 4.14946956 |
63 | fatty acid oxidation (GO:0019395) | 4.12108445 |
64 | urate metabolic process (GO:0046415) | 4.11981727 |
65 | glutamate metabolic process (GO:0006536) | 4.11309860 |
66 | regulation of fibrinolysis (GO:0051917) | 4.08776089 |
67 | tyrosine metabolic process (GO:0006570) | 4.07423122 |
68 | ketone body metabolic process (GO:1902224) | 4.05866666 |
69 | lipid oxidation (GO:0034440) | 4.04251111 |
70 | regulation of plasminogen activation (GO:0010755) | 4.03127310 |
71 | cellular modified amino acid catabolic process (GO:0042219) | 4.02272035 |
72 | serine family amino acid metabolic process (GO:0009069) | 4.01250799 |
73 | 2-oxoglutarate metabolic process (GO:0006103) | 4.00886751 |
74 | regulation of cholesterol esterification (GO:0010872) | 3.98917575 |
75 | carnitine metabolic process (GO:0009437) | 3.97709905 |
76 | response to nitrosative stress (GO:0051409) | 3.97335911 |
77 | indolalkylamine metabolic process (GO:0006586) | 3.94356047 |
78 | flavonoid metabolic process (GO:0009812) | 3.93591077 |
79 | acylglycerol homeostasis (GO:0055090) | 3.91974578 |
80 | triglyceride homeostasis (GO:0070328) | 3.91974578 |
81 | bile acid and bile salt transport (GO:0015721) | 3.91931108 |
82 | alkaloid metabolic process (GO:0009820) | 3.91823139 |
83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90999827 |
84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90999827 |
85 | exogenous drug catabolic process (GO:0042738) | 3.90800695 |
86 | regulation of complement activation (GO:0030449) | 3.90695825 |
87 | negative regulation of sterol transport (GO:0032372) | 3.89706061 |
88 | negative regulation of cholesterol transport (GO:0032375) | 3.89706061 |
89 | negative regulation of coagulation (GO:0050819) | 3.89275996 |
90 | coenzyme catabolic process (GO:0009109) | 3.89251614 |
91 | reverse cholesterol transport (GO:0043691) | 3.89120731 |
92 | protein-lipid complex assembly (GO:0065005) | 3.87625210 |
93 | fatty acid catabolic process (GO:0009062) | 3.86736781 |
94 | monocarboxylic acid catabolic process (GO:0072329) | 3.85422578 |
95 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85185473 |
96 | protein-lipid complex remodeling (GO:0034368) | 3.85185473 |
97 | macromolecular complex remodeling (GO:0034367) | 3.85185473 |
98 | amine catabolic process (GO:0009310) | 3.84987376 |
99 | cellular biogenic amine catabolic process (GO:0042402) | 3.84987376 |
100 | organic acid catabolic process (GO:0016054) | 3.83214184 |
101 | carboxylic acid catabolic process (GO:0046395) | 3.83214184 |
102 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.79621288 |
103 | phospholipid efflux (GO:0033700) | 3.78422344 |
104 | valine metabolic process (GO:0006573) | 3.76911366 |
105 | negative regulation of wound healing (GO:0061045) | 3.75604593 |
106 | negative regulation of protein activation cascade (GO:2000258) | 3.75223467 |
107 | xenobiotic catabolic process (GO:0042178) | 3.75046623 |
108 | positive regulation of lipid catabolic process (GO:0050996) | 3.74292183 |
109 | drug transport (GO:0015893) | 3.73897043 |
110 | protein activation cascade (GO:0072376) | 3.73744463 |
111 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73646446 |
112 | arginine metabolic process (GO:0006525) | 3.71481920 |
113 | plasma lipoprotein particle organization (GO:0071827) | 3.69244616 |
114 | glycine metabolic process (GO:0006544) | 3.68254093 |
115 | serine family amino acid biosynthetic process (GO:0009070) | 3.66366285 |
116 | plasma lipoprotein particle clearance (GO:0034381) | 3.66042611 |
117 | aldehyde catabolic process (GO:0046185) | 3.63717646 |
118 | regulation of cholesterol homeostasis (GO:2000188) | 3.59598394 |
119 | ethanol metabolic process (GO:0006067) | 3.57012340 |
120 | phospholipid homeostasis (GO:0055091) | 3.55869558 |
121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55077021 |
122 | regulation of cholesterol metabolic process (GO:0090181) | 3.54712945 |
123 | heme transport (GO:0015886) | 3.54358034 |
124 | drug metabolic process (GO:0017144) | 3.53474199 |
125 | complement activation, classical pathway (GO:0006958) | 3.52013251 |
126 | protein-lipid complex subunit organization (GO:0071825) | 3.49349228 |
127 | response to mercury ion (GO:0046689) | 3.47267962 |
128 | primary alcohol catabolic process (GO:0034310) | 3.47102349 |
129 | polyketide metabolic process (GO:0030638) | 3.46939547 |
130 | doxorubicin metabolic process (GO:0044598) | 3.46939547 |
131 | daunorubicin metabolic process (GO:0044597) | 3.46939547 |
132 | lipoprotein metabolic process (GO:0042157) | 3.46764185 |
133 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46463009 |
134 | branched-chain amino acid catabolic process (GO:0009083) | 3.46100264 |
135 | cholesterol efflux (GO:0033344) | 3.44394799 |
136 | negative regulation of lipase activity (GO:0060192) | 3.41203261 |
137 | xenobiotic metabolic process (GO:0006805) | 3.36384366 |
138 | positive regulation of blood coagulation (GO:0030194) | 3.35828957 |
139 | positive regulation of hemostasis (GO:1900048) | 3.35828957 |
140 | cholesterol homeostasis (GO:0042632) | 3.33807634 |
141 | complement activation (GO:0006956) | 3.29811514 |
142 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.28631688 |
143 | sterol homeostasis (GO:0055092) | 3.28298852 |
144 | acute-phase response (GO:0006953) | 3.27647301 |
145 | regulation of humoral immune response (GO:0002920) | 3.25073220 |
146 | S-adenosylmethionine metabolic process (GO:0046500) | 3.23921021 |
147 | angiotensin maturation (GO:0002003) | 3.18502837 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.53689899 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.53869824 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.97101900 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.81901641 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.61356070 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.56357726 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.12553338 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74741451 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.21077708 |
10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44427171 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05172836 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4861409 |
13 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95790887 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90882712 |
15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69837497 |
16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69665342 |
17 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.62691677 |
18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49804670 |
19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48289848 |
20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39344205 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34485611 |
22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30327025 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29740481 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27029893 |
25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23031877 |
26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20603013 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20119135 |
28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18887960 |
29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14235681 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13654279 |
31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07864779 |
32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07430545 |
33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06966884 |
34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05484416 |
35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05346299 |
36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04694396 |
37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02238945 |
38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98987609 |
39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97432531 |
40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93366412 |
41 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93117037 |
42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91273795 |
43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90948280 |
44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89066318 |
45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88636932 |
46 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88202980 |
47 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87614345 |
48 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87614345 |
49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87342650 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86834019 |
51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85876920 |
52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84501319 |
53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82014446 |
54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81783384 |
55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81031920 |
56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80973768 |
57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80751409 |
58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80457703 |
59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77412221 |
60 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77136237 |
61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.76872159 |
62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76436182 |
63 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75766655 |
64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75077758 |
65 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75077758 |
66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74203408 |
67 | TP53_16413492_ChIP-PET_HCT116_Human | 0.73579533 |
68 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73309580 |
69 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73133526 |
70 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72985744 |
71 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72616304 |
72 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72410743 |
73 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72244899 |
74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71579319 |
75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71523916 |
76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71478858 |
77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70721119 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69718540 |
79 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69112797 |
80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.68746554 |
81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68735828 |
82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66826254 |
83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66822475 |
84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65476630 |
85 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.65470670 |
86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64819135 |
87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.64770686 |
88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.64614881 |
89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.64199909 |
90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.63869362 |
91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.63819635 |
92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63489161 |
93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63215179 |
94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62665535 |
95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.62578479 |
96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61784814 |
97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61485543 |
98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61170745 |
99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60893897 |
100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59134758 |
101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59130367 |
102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58428047 |
103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55959649 |
104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55311305 |
105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55283329 |
106 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55174958 |
107 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54290434 |
108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52876113 |
109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.52620701 |
110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52511191 |
111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52461020 |
112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52384232 |
113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51551743 |
114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.50936612 |
115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50901528 |
116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50855853 |
117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50188045 |
118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48556549 |
119 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.48441181 |
120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.48373011 |
121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.47750463 |
122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47745244 |
123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47311665 |
124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.46829591 |
125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45215135 |
126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45034331 |
127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44980006 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.61616612 |
2 | MP0005360_urolithiasis | 7.48525097 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.76413031 |
4 | MP0005365_abnormal_bile_salt | 5.66325536 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.46608650 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.86402334 |
7 | MP0003252_abnormal_bile_duct | 3.83446973 |
8 | MP0010329_abnormal_lipoprotein_level | 3.22169991 |
9 | MP0005332_abnormal_amino_acid | 3.15294688 |
10 | MP0003195_calcinosis | 2.94729122 |
11 | MP0009840_abnormal_foam_cell | 2.83791310 |
12 | MP0001666_abnormal_nutrient_absorption | 2.62676610 |
13 | MP0004019_abnormal_vitamin_homeostasis | 2.54482089 |
14 | MP0005083_abnormal_biliary_tract | 2.52964381 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.31600493 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.09940209 |
17 | * MP0002118_abnormal_lipid_homeostasis | 2.05406894 |
18 | * MP0000609_abnormal_liver_physiology | 1.96021221 |
19 | MP0009643_abnormal_urine_homeostasis | 1.81848600 |
20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.79184865 |
21 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72563858 |
22 | MP0004043_abnormal_pH_regulation | 1.64883507 |
23 | MP0003868_abnormal_feces_composition | 1.57287621 |
24 | MP0003183_abnormal_peptide_metabolism | 1.50700780 |
25 | MP0005451_abnormal_body_composition | 1.49377200 |
26 | MP0003186_abnormal_redox_activity | 1.48222720 |
27 | MP0001764_abnormal_homeostasis | 1.45468343 |
28 | MP0005636_abnormal_mineral_homeostasis | 1.32212831 |
29 | MP0005670_abnormal_white_adipose | 1.19929138 |
30 | MP0006036_abnormal_mitochondrial_physio | 1.17099499 |
31 | MP0004130_abnormal_muscle_cell | 1.13238702 |
32 | MP0005409_darkened_coat_color | 1.09548659 |
33 | MP0002837_dystrophic_cardiac_calcinosis | 1.08559117 |
34 | MP0001756_abnormal_urination | 1.06768997 |
35 | MP0003656_abnormal_erythrocyte_physiolo | 1.03544370 |
36 | * MP0000598_abnormal_liver_morphology | 1.02518016 |
37 | MP0009764_decreased_sensitivity_to | 0.98829544 |
38 | MP0003879_abnormal_hair_cell | 0.96383544 |
39 | MP0000604_amyloidosis | 0.96062408 |
40 | MP0009697_abnormal_copulation | 0.95017278 |
41 | MP0003011_delayed_dark_adaptation | 0.92917953 |
42 | MP0002136_abnormal_kidney_physiology | 0.92738572 |
43 | MP0009763_increased_sensitivity_to | 0.89845084 |
44 | MP0005666_abnormal_adipose_tissue | 0.87848355 |
45 | MP0001765_abnormal_ion_homeostasis | 0.87836590 |
46 | MP0000566_synostosis | 0.87522665 |
47 | * MP0009642_abnormal_blood_homeostasis | 0.86504431 |
48 | MP0003866_abnormal_defecation | 0.86046785 |
49 | MP0010155_abnormal_intestine_physiology | 0.85304916 |
50 | MP0005647_abnormal_sex_gland | 0.85272420 |
51 | MP0005408_hypopigmentation | 0.85150710 |
52 | MP0001664_abnormal_digestion | 0.84617549 |
53 | MP0003690_abnormal_glial_cell | 0.84037387 |
54 | MP0002971_abnormal_brown_adipose | 0.83883428 |
55 | MP0005535_abnormal_body_temperature | 0.82373347 |
56 | * MP0008469_abnormal_protein_level | 0.81765403 |
57 | MP0002876_abnormal_thyroid_physiology | 0.79907675 |
58 | MP0010368_abnormal_lymphatic_system | 0.79570096 |
59 | MP0005084_abnormal_gallbladder_morpholo | 0.79088516 |
60 | MP0003705_abnormal_hypodermis_morpholog | 0.78399846 |
61 | MP0003329_amyloid_beta_deposits | 0.78165731 |
62 | * MP0002078_abnormal_glucose_homeostasis | 0.78094866 |
63 | MP0002254_reproductive_system_inflammat | 0.73317523 |
64 | MP0005376_homeostasis/metabolism_phenot | 0.73164822 |
65 | MP0001661_extended_life_span | 0.72933112 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 0.71258674 |
67 | MP0009765_abnormal_xenobiotic_induced | 0.70943898 |
68 | MP0005334_abnormal_fat_pad | 0.70085268 |
69 | MP0005266_abnormal_metabolism | 0.69582097 |
70 | MP0003300_gastrointestinal_ulcer | 0.67943890 |
71 | MP0000477_abnormal_intestine_morphology | 0.66645169 |
72 | MP0005058_abnormal_lysosome_morphology | 0.66471564 |
73 | MP0005220_abnormal_exocrine_pancreas | 0.64986741 |
74 | MP0004147_increased_porphyrin_level | 0.64657593 |
75 | MP0006035_abnormal_mitochondrial_morpho | 0.63822280 |
76 | MP0002132_abnormal_respiratory_system | 0.63772868 |
77 | MP0000230_abnormal_systemic_arterial | 0.60688481 |
78 | MP0005330_cardiomyopathy | 0.59030807 |
79 | MP0001663_abnormal_digestive_system | 0.58648134 |
80 | MP0003724_increased_susceptibility_to | 0.58361640 |
81 | MP0004264_abnormal_extraembryonic_tissu | 0.57336307 |
82 | MP0000249_abnormal_blood_vessel | 0.57105451 |
83 | MP0010352_gastrointestinal_tract_polyps | 0.54020688 |
84 | MP0002928_abnormal_bile_duct | 0.51723142 |
85 | MP0003718_maternal_effect | 0.51639831 |
86 | MP0005448_abnormal_energy_balance | 0.49848864 |
87 | MP0002166_altered_tumor_susceptibility | 0.49456194 |
88 | MP0005381_digestive/alimentary_phenotyp | 0.47413955 |
89 | MP0002796_impaired_skin_barrier | 0.46847983 |
90 | MP0003638_abnormal_response/metabolism_ | 0.45978767 |
91 | MP0005164_abnormal_response_to | 0.45822619 |
92 | MP0005023_abnormal_wound_healing | 0.45581897 |
93 | MP0002168_other_aberrant_phenotype | 0.44381500 |
94 | MP0002822_catalepsy | 0.43616670 |
95 | MP0001915_intracranial_hemorrhage | 0.43447569 |
96 | MP0003953_abnormal_hormone_level | 0.43210454 |
97 | MP0008874_decreased_physiological_sensi | 0.42868267 |
98 | MP0005187_abnormal_penis_morphology | 0.42166999 |
99 | MP0009115_abnormal_fat_cell | 0.41361738 |
100 | MP0008873_increased_physiological_sensi | 0.41146505 |
101 | MP0010234_abnormal_vibrissa_follicle | 0.40805876 |
102 | MP0003646_muscle_fatigue | 0.40414878 |
103 | MP0005395_other_phenotype | 0.40369142 |
104 | MP0002009_preneoplasia | 0.39567612 |
105 | MP0008872_abnormal_physiological_respon | 0.39172890 |
106 | MP0002089_abnormal_postnatal_growth/wei | 0.38608445 |
107 | MP0003075_altered_response_to | 0.38453386 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.38406088 |
109 | MP0001873_stomach_inflammation | 0.38369896 |
110 | MP0004272_abnormal_basement_membrane | 0.38129905 |
111 | MP0005464_abnormal_platelet_physiology | 0.37967312 |
112 | MP0005375_adipose_tissue_phenotype | 0.37670626 |
113 | MP0005166_decreased_susceptibility_to | 0.36803740 |
114 | MP0004883_abnormal_blood_vessel | 0.36254287 |
115 | MP0009384_cardiac_valve_regurgitation | 0.35829513 |
116 | MP0005165_increased_susceptibility_to | 0.34889531 |
117 | MP0005167_abnormal_blood-brain_barrier | 0.34523392 |
118 | MP0000538_abnormal_urinary_bladder | 0.34097963 |
119 | MP0003045_fibrosis | 0.32753336 |
120 | MP0008961_abnormal_basal_metabolism | 0.32174707 |
121 | MP0003959_abnormal_lean_body | 0.32119810 |
122 | MP0000467_abnormal_esophagus_morphology | 0.31251897 |
123 | MP0002098_abnormal_vibrissa_morphology | 0.30949536 |
124 | MP0000639_abnormal_adrenal_gland | 0.30854102 |
125 | MP0000462_abnormal_digestive_system | 0.30821966 |
126 | MP0002135_abnormal_kidney_morphology | 0.30711202 |
127 | MP0004782_abnormal_surfactant_physiolog | 0.30424914 |
128 | MP0004036_abnormal_muscle_relaxation | 0.30411848 |
129 | MP0002970_abnormal_white_adipose | 0.30409559 |
130 | MP0002269_muscular_atrophy | 0.30393804 |
131 | MP0002896_abnormal_bone_mineralization | 0.29645841 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23564584 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.18150630 |
3 | Deep venous thrombosis (HP:0002625) | 5.76715840 |
4 | Xanthomatosis (HP:0000991) | 5.46229831 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.42633471 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.06118309 |
7 | Hyperglycinuria (HP:0003108) | 4.75630003 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 4.72827486 |
9 | Hyperammonemia (HP:0001987) | 4.64959622 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.62735814 |
11 | Ketosis (HP:0001946) | 4.56739710 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.50111918 |
13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.49563220 |
14 | Abnormality of glycine metabolism (HP:0010895) | 4.49563220 |
15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.28852664 |
16 | Hyperglycinemia (HP:0002154) | 4.25985096 |
17 | Glomerulonephritis (HP:0000099) | 4.21792342 |
18 | Hypoglycemic coma (HP:0001325) | 4.10243133 |
19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.05875709 |
20 | Complement deficiency (HP:0004431) | 4.05756666 |
21 | Hypolipoproteinemia (HP:0010981) | 3.90749494 |
22 | Ketoacidosis (HP:0001993) | 3.87769258 |
23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85661048 |
24 | Epidermoid cyst (HP:0200040) | 3.78309034 |
25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67779692 |
26 | Fat malabsorption (HP:0002630) | 3.67474669 |
27 | Joint hemorrhage (HP:0005261) | 3.62493493 |
28 | Gout (HP:0001997) | 3.60697051 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 3.47305630 |
30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47153723 |
31 | Abnormality of methionine metabolism (HP:0010901) | 3.46713711 |
32 | Dicarboxylic aciduria (HP:0003215) | 3.34577842 |
33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.34577842 |
34 | Abnormality of purine metabolism (HP:0004352) | 3.31769795 |
35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29687057 |
36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.19843902 |
37 | Flat acetabular roof (HP:0003180) | 3.15810993 |
38 | Metabolic acidosis (HP:0001942) | 3.15388020 |
39 | Generalized aminoaciduria (HP:0002909) | 3.15367585 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13736306 |
41 | Nephritis (HP:0000123) | 3.08913883 |
42 | Hypercholesterolemia (HP:0003124) | 3.05555839 |
43 | Proximal tubulopathy (HP:0000114) | 3.04673572 |
44 | Delayed CNS myelination (HP:0002188) | 3.01274613 |
45 | Hyperbilirubinemia (HP:0002904) | 2.97356122 |
46 | Abnormality of serum amino acid levels (HP:0003112) | 2.94070676 |
47 | Abnormality of complement system (HP:0005339) | 2.83297352 |
48 | Lethargy (HP:0001254) | 2.81945950 |
49 | Abnormality of the intrinsic pathway (HP:0010989) | 2.78049992 |
50 | Vascular calcification (HP:0004934) | 2.77673844 |
51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.77669328 |
52 | Gingival bleeding (HP:0000225) | 2.76262791 |
53 | Steatorrhea (HP:0002570) | 2.74369719 |
54 | Alkalosis (HP:0001948) | 2.73288916 |
55 | Menorrhagia (HP:0000132) | 2.72647114 |
56 | Hyperuricemia (HP:0002149) | 2.70133166 |
57 | Increased purine levels (HP:0004368) | 2.70133166 |
58 | Hepatocellular carcinoma (HP:0001402) | 2.61368293 |
59 | Osteomalacia (HP:0002749) | 2.59141682 |
60 | Poikilocytosis (HP:0004447) | 2.57950082 |
61 | Malnutrition (HP:0004395) | 2.55888741 |
62 | Cerebral edema (HP:0002181) | 2.51838254 |
63 | Abnormality of urine glucose concentration (HP:0011016) | 2.50667365 |
64 | Glycosuria (HP:0003076) | 2.50667365 |
65 | Abnormal tarsal ossification (HP:0008369) | 2.48700904 |
66 | Vomiting (HP:0002013) | 2.46367435 |
67 | Cardiovascular calcification (HP:0011915) | 2.45562562 |
68 | Ileus (HP:0002595) | 2.43859783 |
69 | Abnormality of proline metabolism (HP:0010907) | 2.39600460 |
70 | Hydroxyprolinuria (HP:0003080) | 2.39600460 |
71 | Sensorimotor neuropathy (HP:0007141) | 2.36466677 |
72 | Hypophosphatemic rickets (HP:0004912) | 2.35694487 |
73 | Myocardial infarction (HP:0001658) | 2.33365753 |
74 | Abnormality of renin-angiotensin system (HP:0000847) | 2.31323056 |
75 | Skin nodule (HP:0200036) | 2.30993420 |
76 | Spastic diplegia (HP:0001264) | 2.27927112 |
77 | Irritability (HP:0000737) | 2.25846778 |
78 | Decreased circulating renin level (HP:0003351) | 2.24213456 |
79 | Purpura (HP:0000979) | 2.23017652 |
80 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21784736 |
81 | Acanthocytosis (HP:0001927) | 2.21335844 |
82 | Hypoglycemic seizures (HP:0002173) | 2.20863635 |
83 | Hypokalemic alkalosis (HP:0001949) | 2.20558675 |
84 | Hyperphosphaturia (HP:0003109) | 2.19876606 |
85 | Rickets (HP:0002748) | 2.16538840 |
86 | Renal cortical cysts (HP:0000803) | 2.16174306 |
87 | Late onset (HP:0003584) | 2.15107632 |
88 | Abnormal gallbladder morphology (HP:0012437) | 2.14561566 |
89 | Abnormality of carpal bone ossification (HP:0006257) | 2.14103455 |
90 | Neonatal onset (HP:0003623) | 2.13608920 |
91 | Widely patent fontanelles and sutures (HP:0004492) | 2.10812502 |
92 | Cholelithiasis (HP:0001081) | 2.10154425 |
93 | Potter facies (HP:0002009) | 2.09468539 |
94 | Facial shape deformation (HP:0011334) | 2.09468539 |
95 | Spontaneous abortion (HP:0005268) | 2.09139784 |
96 | Pancreatitis (HP:0001733) | 2.08717485 |
97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07684213 |
98 | Pigmentary retinal degeneration (HP:0001146) | 2.07346550 |
99 | Abdominal distention (HP:0003270) | 2.07059733 |
100 | Increased circulating renin level (HP:0000848) | 2.05838683 |
101 | Abnormal gallbladder physiology (HP:0012438) | 2.05337934 |
102 | Cholecystitis (HP:0001082) | 2.05337934 |
103 | Enlarged kidneys (HP:0000105) | 2.04954635 |
104 | Systemic lupus erythematosus (HP:0002725) | 2.03293015 |
105 | Metabolic alkalosis (HP:0200114) | 2.03284628 |
106 | Esophageal varix (HP:0002040) | 2.02558890 |
107 | Mitral stenosis (HP:0001718) | 2.01744408 |
108 | Myoglobinuria (HP:0002913) | 2.00929688 |
109 | Abnormal urine phosphate concentration (HP:0012599) | 1.98225213 |
110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97672638 |
111 | Abnormality of vitamin metabolism (HP:0100508) | 1.97656218 |
112 | Hypochromic microcytic anemia (HP:0004840) | 1.97344878 |
113 | Nausea (HP:0002018) | 1.95840573 |
114 | Abnormal cartilage morphology (HP:0002763) | 1.93739290 |
115 | Hypophosphatemia (HP:0002148) | 1.92096207 |
116 | Renal tubular acidosis (HP:0001947) | 1.91357903 |
117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89127494 |
118 | Hypokalemia (HP:0002900) | 1.88548277 |
119 | Focal segmental glomerulosclerosis (HP:0000097) | 1.86654154 |
120 | Hepatic necrosis (HP:0002605) | 1.86240377 |
121 | Arthropathy (HP:0003040) | 1.84173635 |
122 | Cerebral palsy (HP:0100021) | 1.83493546 |
123 | Nephrolithiasis (HP:0000787) | 1.83392731 |
124 | Brushfield spots (HP:0001088) | 1.81560105 |
125 | Thrombophlebitis (HP:0004418) | 1.80033474 |
126 | Abnormality of chloride homeostasis (HP:0011422) | 1.77840642 |
127 | Elevated hepatic transaminases (HP:0002910) | 1.77475828 |
128 | Fair hair (HP:0002286) | 1.77363711 |
129 | Increased mean platelet volume (HP:0011877) | 1.77359871 |
130 | Hemorrhage of the eye (HP:0011885) | 1.77335320 |
131 | Abnormality of potassium homeostasis (HP:0011042) | 1.77183042 |
132 | Abnormality of the gallbladder (HP:0005264) | 1.77012696 |
133 | Abnormal hand bone ossification (HP:0010660) | 1.75304807 |
134 | Hyperaldosteronism (HP:0000859) | 1.73793192 |
135 | Glomerulosclerosis (HP:0000096) | 1.71071409 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.27066345 |
2 | ACVR1B | 4.68027408 |
3 | FGFR4 | 3.35400499 |
4 | SIK1 | 3.18626422 |
5 | WNK4 | 3.05256162 |
6 | ERN1 | 2.99920630 |
7 | AKT3 | 2.90701899 |
8 | OXSR1 | 2.65172311 |
9 | EPHA2 | 2.52768652 |
10 | MST1R | 2.47247317 |
11 | INSRR | 2.37343087 |
12 | WNK3 | 2.10341911 |
13 | PKN2 | 2.03031335 |
14 | EPHB1 | 2.02352023 |
15 | STK39 | 1.99564690 |
16 | ERBB4 | 1.81039414 |
17 | TAOK3 | 1.74828967 |
18 | TRIB3 | 1.74331003 |
19 | MAP3K7 | 1.68555796 |
20 | FRK | 1.66204023 |
21 | PDK4 | 1.63677154 |
22 | PDK3 | 1.63677154 |
23 | PINK1 | 1.35829488 |
24 | MAPK11 | 1.35648032 |
25 | MAPKAPK3 | 1.32651572 |
26 | FLT3 | 1.32506488 |
27 | MAP2K4 | 1.31213243 |
28 | FGFR2 | 1.31141340 |
29 | PTK6 | 1.25886047 |
30 | MAP2K3 | 1.24926946 |
31 | PRKAA2 | 1.24116314 |
32 | MAP3K3 | 1.23693548 |
33 | SGK494 | 1.16940879 |
34 | SGK223 | 1.16940879 |
35 | FER | 1.15779285 |
36 | TIE1 | 1.15737641 |
37 | MYLK | 1.15303239 |
38 | GRK6 | 1.15212807 |
39 | NEK9 | 1.14101187 |
40 | LMTK2 | 1.13272122 |
41 | TYK2 | 1.13043584 |
42 | EIF2AK1 | 1.12720493 |
43 | PRKG2 | 1.12178429 |
44 | MET | 1.11446971 |
45 | MAP3K2 | 1.10960004 |
46 | EEF2K | 1.09197352 |
47 | SGK3 | 1.08733528 |
48 | STK38L | 1.08254849 |
49 | CDK12 | 1.08177289 |
50 | PDK2 | 1.05196810 |
51 | LATS1 | 1.02159168 |
52 | JAK2 | 1.00495947 |
53 | PIK3CA | 0.96853228 |
54 | PIK3CG | 0.96090347 |
55 | NLK | 0.95668208 |
56 | KDR | 0.92337261 |
57 | PDGFRA | 0.89010517 |
58 | SGK2 | 0.87214168 |
59 | TGFBR2 | 0.82880424 |
60 | RIPK1 | 0.82403307 |
61 | CDC42BPA | 0.81040041 |
62 | DDR2 | 0.80303343 |
63 | ABL2 | 0.80177750 |
64 | JAK1 | 0.79930918 |
65 | CAMK1D | 0.79818134 |
66 | PAK3 | 0.77971203 |
67 | MAPK15 | 0.76810063 |
68 | PDPK1 | 0.75994436 |
69 | GSK3A | 0.74207805 |
70 | PRKAA1 | 0.72733526 |
71 | MAP3K12 | 0.72014690 |
72 | TTN | 0.71976535 |
73 | BRSK2 | 0.69152242 |
74 | MAPK12 | 0.68138210 |
75 | MAP2K6 | 0.67554444 |
76 | MAPK4 | 0.66397463 |
77 | MAP3K10 | 0.66274667 |
78 | PRKCH | 0.64274310 |
79 | PRKCQ | 0.64074038 |
80 | TRPM7 | 0.62941127 |
81 | ICK | 0.62331828 |
82 | LRRK2 | 0.61239558 |
83 | YES1 | 0.60527008 |
84 | IGF1R | 0.59733549 |
85 | MAP2K1 | 0.59668271 |
86 | PRKACG | 0.59353034 |
87 | WNK1 | 0.57999427 |
88 | TBK1 | 0.57580275 |
89 | MAP2K2 | 0.57365490 |
90 | PDK1 | 0.56848258 |
91 | MAP3K14 | 0.56548687 |
92 | EPHA3 | 0.56127975 |
93 | CSK | 0.56068073 |
94 | ITK | 0.55781712 |
95 | FGFR3 | 0.55406354 |
96 | CAMK2G | 0.54621401 |
97 | DAPK2 | 0.53623681 |
98 | PRKCZ | 0.52986683 |
99 | ERBB2 | 0.52230912 |
100 | GRK1 | 0.51708035 |
101 | CSNK1G1 | 0.51229362 |
102 | KSR2 | 0.48049846 |
103 | RET | 0.47580251 |
104 | PRKD1 | 0.46734241 |
105 | PTK2 | 0.46218445 |
106 | MST4 | 0.45963201 |
107 | MAP3K1 | 0.45882307 |
108 | FGFR1 | 0.44855060 |
109 | PHKG1 | 0.44770015 |
110 | PHKG2 | 0.44770015 |
111 | MAPK7 | 0.44533768 |
112 | BCR | 0.44352395 |
113 | CDK6 | 0.44053356 |
114 | CAMKK2 | 0.43824421 |
115 | IKBKE | 0.42951992 |
116 | MELK | 0.41996243 |
117 | NEK6 | 0.41668101 |
118 | CAMK1G | 0.40464231 |
119 | STK24 | 0.40314025 |
120 | NEK1 | 0.39947400 |
121 | CSF1R | 0.39291045 |
122 | DYRK1B | 0.38887778 |
123 | STK38 | 0.38566873 |
124 | STK3 | 0.37912113 |
125 | SGK1 | 0.37640561 |
126 | TESK2 | 0.36893613 |
127 | PKN1 | 0.36844056 |
128 | PDGFRB | 0.36600463 |
129 | MAP4K1 | 0.36168169 |
130 | IRAK3 | 0.36107639 |
131 | STK10 | 0.35904123 |
132 | MTOR | 0.35674762 |
133 | ZAP70 | 0.35144940 |
134 | RPS6KB1 | 0.34992808 |
135 | SRC | 0.34599354 |
136 | PRKCA | 0.33374937 |
137 | PRKG1 | 0.31362981 |
138 | BMPR1B | 0.27720995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.68886915 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47831800 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.03403941 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90805031 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83006176 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.73560137 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65492838 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61191331 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58378308 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.55060935 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.52944323 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51523623 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46208775 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29596570 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26140303 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.15849848 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09045842 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05339253 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03108573 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00071808 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99496666 |
22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96431854 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91867297 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85035602 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81965095 |
26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78082043 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77579081 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69230754 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67762689 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64002417 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.54770557 |
32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53827712 |
33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53550462 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48912376 |
35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46131939 |
36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43392914 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38581012 |
38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38119556 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33636992 |
40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32256027 |
41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29506798 |
42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24789791 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24423510 |
44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17482411 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.14576714 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14144267 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13343096 |
48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12173088 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10644538 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08166520 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07629509 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05973446 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05279939 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03572510 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98396322 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97464720 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93152570 |
58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91139035 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.90241074 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82699236 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81375933 |
62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76741337 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67202721 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58654064 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55618591 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48759394 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45926039 |
68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35178400 |
69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35105459 |
70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35035046 |
71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30730148 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30618329 |
73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29522808 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.29434159 |
75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28932734 |
76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26637500 |
77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15133704 |
78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14658803 |
79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13859685 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13517596 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.12701105 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.11365023 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10551921 |
84 | Pertussis_Homo sapiens_hsa05133 | 0.09809358 |
85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08902311 |
86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06570141 |
87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2013972 |
88 | Lysosome_Homo sapiens_hsa04142 | -0.1896676 |
89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1790869 |
90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1667011 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1659668 |
92 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1516059 |
93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1410759 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1267602 |
95 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1258957 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0885856 |
97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0881792 |
98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0838957 |
99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0770416 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0681775 |
101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0671225 |
102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0664686 |
103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0651097 |
104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0491624 |
105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0371675 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0324711 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0092193 |
108 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0039072 |